BR112013025610A2 - uso de um metapneumovírus aviário vivo, e, composição farmacêutica - Google Patents

uso de um metapneumovírus aviário vivo, e, composição farmacêutica

Info

Publication number
BR112013025610A2
BR112013025610A2 BR112013025610A BR112013025610A BR112013025610A2 BR 112013025610 A2 BR112013025610 A2 BR 112013025610A2 BR 112013025610 A BR112013025610 A BR 112013025610A BR 112013025610 A BR112013025610 A BR 112013025610A BR 112013025610 A2 BR112013025610 A2 BR 112013025610A2
Authority
BR
Brazil
Prior art keywords
avian metapneumovirus
pharmaceutical composition
live avian
live
metapneumovirus
Prior art date
Application number
BR112013025610A
Other languages
English (en)
Inventor
Carla Christina Schrier
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of BR112013025610A2 publication Critical patent/BR112013025610A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A61K35/768—Oncolytic viruses not provided for in groups A61K35/761 - A61K35/766
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18311—Metapneumovirus, e.g. avian pneumovirus
    • C12N2760/18332—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Abstract

metapneumovírus aviário vivo, e, composição farmacêutica a presente invenção se refere a metapneumovírus aviário vivo (ampv) para uso em terapia de câncer, e a composições farmacêuticas para uso em terapia de câncer compreendendo uma quantidade citotóxica de metapneumovírus aviário vivos (ampv), e um carreador farmaceuticamente aceitável.
BR112013025610A 2011-04-12 2012-04-11 uso de um metapneumovírus aviário vivo, e, composição farmacêutica BR112013025610A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11162008 2011-04-12
PCT/EP2012/056506 WO2012140032A1 (en) 2011-04-12 2012-04-11 Avian metapneumovirus in oncolysis

Publications (1)

Publication Number Publication Date
BR112013025610A2 true BR112013025610A2 (pt) 2016-12-27

Family

ID=45953140

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013025610A BR112013025610A2 (pt) 2011-04-12 2012-04-11 uso de um metapneumovírus aviário vivo, e, composição farmacêutica

Country Status (9)

Country Link
US (1) US20140030230A1 (pt)
EP (1) EP2696881B1 (pt)
JP (1) JP5897700B2 (pt)
CN (2) CN108125989A (pt)
BR (1) BR112013025610A2 (pt)
DK (1) DK2696881T3 (pt)
ES (1) ES2565198T3 (pt)
RU (1) RU2571925C2 (pt)
WO (1) WO2012140032A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104195114A (zh) * 2014-09-05 2014-12-10 青岛易邦生物工程有限公司 一种禽肺病毒及其应用
CN105296440B (zh) * 2015-09-08 2019-01-04 北京市农林科学院 一种鸡C型禽偏肺病毒毒株aMPV/C-JCZ及其应用
CN105296439B (zh) * 2015-09-08 2019-01-04 北京市农林科学院 一种鸡C型禽偏肺病毒毒株aMPV/C-JCX及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI398272B (zh) 2005-03-08 2013-06-11 Intervet Int Bv 化學定義的安定劑
CN101304761A (zh) * 2005-08-31 2008-11-12 昂科利蒂克斯生物科技公司 用溶瘤病毒和免疫刺激剂治疗以增强体内免疫系统对肿瘤的识别
CN101489589A (zh) * 2006-05-19 2009-07-22 沃尔特及伊莱萨霍尔医学研究院 免疫原性组合物
US9937196B2 (en) * 2009-06-19 2018-04-10 University Of Maryland, College Park Genomic sequence of avian paramyxovirus type 2 and uses thereof

Also Published As

Publication number Publication date
CN108125989A (zh) 2018-06-08
CN103491970A (zh) 2014-01-01
EP2696881A1 (en) 2014-02-19
JP5897700B2 (ja) 2016-03-30
DK2696881T3 (en) 2016-05-09
US20140030230A1 (en) 2014-01-30
WO2012140032A1 (en) 2012-10-18
ES2565198T3 (es) 2016-04-01
EP2696881B1 (en) 2016-02-03
RU2571925C2 (ru) 2015-12-27
RU2013150192A (ru) 2015-05-20
JP2014511703A (ja) 2014-05-19

Similar Documents

Publication Publication Date Title
ECSP12012318A (es) Inhibidores de pirazolil quinazolina cinasa
GB201118656D0 (en) New compounds
MX349004B (es) Nuevos compuestos.
UA106636C2 (uk) Морфолінотіазоли як позитивні алостеричні модулятори альфа 7
MX366899B (es) Nuevos compuestos.
MX2014009757A (es) Derivados de isoindolina, composiciones farmaceuticas que los contienen y su uso en terapia.
MX336741B (es) Composiciones farmaceuticas de moduladores de c-met.
CL2013000016A1 (es) Compuestos derivados de imidazopiridina; procedimiento de preparacion; composicion farmaceutica y su uso en el tratamiento del cancer.
CL2013000018A1 (es) Compuestos derivados de indolizina , su procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento del cancer, entre otros.
MX2013011655A (es) Forma de dosis unitaria para administracion oral.
MX2013001677A (es) Formulaciones estables de linaclotida.
BR112012023407A2 (pt) composição em pó farmacêutica para instalação, e, processo para a preparação da mesma.
BR112015031417A2 (pt) forma de dosagem farmacêutica, composição farmacêutica, métodos para tratamento de um paciente com necessidade de cisteamina e para preparo de uma forma de dosagem
EA201591830A1 (ru) Фармацевтические композиции, включающие эверолимус
SV2010003752A (es) Derivados de urea heterociclicos para el tratamiento de infecciones bacterianas
MX2016003522A (es) Derivados de quinazolinas y su uso como inhibidores de la adn metiltransferasa.
CL2011000168A1 (es) Compuestos derivados de narciclasina y pancratistatina; procedimiento de preparación; composición farmacéutica; combinación farmacéutica; y su uso para el tratamiento del cáncer.
EP3311809A4 (en) USE OF A PHARMACEUTICAL COMPOSITION IN THE PREPARATION OF A MEDICAMENT FOR PROMOTING CHONDROCYTE PRODUCTION
DOP2010000400A (es) 7-sulfanilmetil-,7-sulfinilmetil- y 7-sulfonilmetilindoles sustituidos y el uso de los mismos
BR112014009760A2 (pt) análogos de ácido siálico, seu uso e composição farmacêutica e composição farmacêutica de liberação sustentada os compreendendo
BR112013025610A2 (pt) uso de um metapneumovírus aviário vivo, e, composição farmacêutica
MX2015010486A (es) Composicion masticable para administracion oral y proceso para preparar la misma.
EA201791354A3 (ru) Препараты производных пиримидиндиона
CU20130124A7 (es) Derivados de tieno [2,3-d] pirimidina y su uso para el tratamiento de la arritmia
BR112013024196A2 (pt) complexos de gálio, composições farmacêuticas e métodos de uso

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements